ZIVO BIOSCIENCE, INC. Deferred Tax Assets, Net of Valuation Allowance
ZIVO BIOSCIENCE, INC. (ZIVO) had Deferred Tax Assets, Net of Valuation Allowance of $13.73 million as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-03-18
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $13.73M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $12.38M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $10.79M; Deferred Tax Assets, Net of Valuation Allowance as first filed $0.00.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2024-12-31 | $13.73M 10-K · filed 2025-03-18 | |
| 2023-12-31 | $12.38M 10-K · filed 2025-03-18 | |
| 2022-12-31 | $10.79M 10-K · filed 2024-03-15 | $0.00 10-K · filed 2023-03-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-14 | |
| 2020-12-31 | $0.00 10-K · filed 2022-04-22 | |
| 2016-12-31 | $15.89M 10-K · filed 2017-03-31 |